Lineage Cell Therapeutics
LCTX
#8746
Rank
A$0.35 B
Marketcap
A$1.42
Share price
-1.94%
Change (1 day)
-42.09%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2026 (TTM): -A$33.99 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are A$14.77 Million. In 2025 the company made an earning of -A$30.65 Million a decrease over its 2024 earnings that were of -A$30.22 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$33.99 Million10.91%
2025 -A$30.65 Million1.4%
2024 -A$30.22 Million-13.16%
2023 -A$34.8 Million9.83%
2022 -A$31.69 Million-54.24%
2021 -A$69.24 Million86.07%
2020 -A$37.21 Million-31.97%
2019 -A$54.7 Million-5.42%
2018 -A$57.83 Million1.1%
2017 -A$57.2 Million-31.06%
2016 -A$82.97 Million-10.38%
2015 -A$92.58 Million29.69%
2014 -A$71.39 Million31.68%
2013 -A$54.22 Million
2011 -A$26.31 Million89.78%
2010 -A$13.87 Million206.06%
2009 -A$4.53 Million-0.58%
2008 -A$4.56 Million164.89%
2007 -A$1.72 Million-30.22%
2006 -A$2.47 Million
2002 -A$2.87 Million-41.04%
2001 -A$4.86 Million-32.04%
2000 -A$7.15 Million-11.85%
1999 -A$8.11 Million
1997 -A$5.21 Million12.12%
1996 -A$4.65 Million106.25%
1995 -A$2.26 Million-11.11%
1994 -A$2.54 Million50%
1993 -A$1.69 Million20%
1992 -A$1.41 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.22 Billion 555.55%๐Ÿ‡บ๐Ÿ‡ธ USA